S.3872: Promising Pathway Act

About This Bill

Bill Sponsor

Bill Version

Bill Summary

Promising Pathway Act This bill establishes a provisional approval pathway for medicines intended for serious or life-threatening diseases, including illnesses posing a threat of epidemic or pandemic. The period of the provisional approval is for two years and is potentially renewable. The Food and Drug Administration (FDA) must establish a priority review system to evaluate completed provisional approval applications within 90 days of...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There are 2 statements associated with S.3872.

Bill Actions

Date Description
June 3, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
June 3, 2020

Introduced in the Senate by Mike Braun (R-Ind.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page